Spots Global Cancer Trial Database for somatostatin
Every month we try and update this database with for somatostatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery | NCT03734627 | Esophageal Canc... Nutrition Disor... Appetite Disord... Dumping Syndrom... Delayed Gastric... Surgery | Octreotide Acet... Saline Solution Paracetamol Sulfasalazine Duodenal biopsy | 18 Years - | St. James's Hospital, Ireland | |
The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | NCT02381249 | Esophageal Neop... Stomach Neoplas... Weight Loss Malnutrition Pancreatic Neop... Duodenal Neopla... | Octreotide Placebo | 18 Years - 100 Years | St. James's Hospital, Ireland | |
Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer | NCT01417806 | Small Cell Lung... | Topotecan and P... | 18 Years - | South Florida Veterans Affairs Foundation for Research and Education | |
Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer | NCT02385617 | Esophageal Neop... Stomach Neoplas... Weight Loss Malnutrition | Octreotide Placebo | 18 Years - 100 Years | St. James's Hospital, Ireland | |
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly | NCT00001860 | Acromegaly Pituitary Neopl... | Sandostatin LAR... | - | National Institutes of Health Clinical Center (CC) | |
DOTA-TOC in Metastasized Neuroendocrine Tumors | NCT00978211 | Neuroendocrine ... | DOTA-TOC Treatm... | - | University Hospital, Basel, Switzerland | |
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma | NCT01053390 | Gallbladder Neo... | Somatostatin epirubicin, cis... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | NCT00005906 | Lymphangioleiom... Lymphangiomyoma... Pleural Effusio... Ascites | Octreotide | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma | NCT01053390 | Gallbladder Neo... | Somatostatin epirubicin, cis... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | NCT00005906 | Lymphangioleiom... Lymphangiomyoma... Pleural Effusio... Ascites | Octreotide | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection | NCT01914692 | Gastric Cancer ... | Somatostatin | 18 Years - 70 Years | First Affiliated Hospital, Sun Yat-Sen University | |
Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer | NCT01417806 | Small Cell Lung... | Topotecan and P... | 18 Years - | South Florida Veterans Affairs Foundation for Research and Education | |
The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | NCT02381249 | Esophageal Neop... Stomach Neoplas... Weight Loss Malnutrition Pancreatic Neop... Duodenal Neopla... | Octreotide Placebo | 18 Years - 100 Years | St. James's Hospital, Ireland | |
Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection | NCT01914692 | Gastric Cancer ... | Somatostatin | 18 Years - 70 Years | First Affiliated Hospital, Sun Yat-Sen University |